MediSix Therapeutics

Modulari-T Biosciences

This company develops modular immune receptors and delivery vehicles to create cell and gene therapies for patients with cancer and autoimmune diseases.

EdiTy Therapeutics

This company develops immune cell delivery platforms to transport therapeutic proteins into diseased cells for patients with cancer and genetic disorders.

Vittoria Biotherapeutics

This company develops engineered T-cell therapies for patients with cancer and immunological disorders using its proprietary cell manufacturing platform.

T-Therapeutics

The company develops T cell receptor therapeutics and bispecific engagers for patients with cancer and autoimmune diseases.

Autolus Therapeutics

This company develops programmed T-cell therapies for patients with cancer and autoimmune diseases.

Candid Therapeutics

This clinical-stage biotechnology company develops T-cell engager antibodies for patients with autoimmune and inflammatory diseases.

Medici Therapeutics

The company develops personalised mRNA cancer vaccines and T cell therapies for patients to treat tumours and combat age-related cellular decline.

Ouro Medicines

This biotechnology firm develops T-cell engager therapies to treat patients living with chronic immune-mediated diseases.